SHH-activated MB is the most common subgroup in the adult population, accounting about 60% of adult MBs, with a 5-year overall survival (OS) rate of about 50–70% in the absence of TP53 mutation [22,23,24,25,26,27]. Here, SHH is linked to Mobius syndrome.